Eagle Pharmaceuticals Recalls Argatroban
Eagle Pharmaceuticals issued a recall for four lots of an anticoagulant due to visible particles in the solution that may cause adverse side effects in patients. The Food and Drug Administration reported that the affected lots of Argatroban Injection 50 mg/50 ml (1 mg/mL) may lead to infarction or embolization to organs as well as organ complications. The lot numbers are